Effect of etanercept on tenosynovitis and nodules in rheumatoid arthritis.
Kaiser
M -J
M-
Hôpital Lapeyronie, Montpellier, France.
Bozonnat
M -C
M-
Jorgensen
C
C
Daurès
J -P
J-
Sany
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000473:pathology; D002648:Child; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage*; D013717:Tenosynovitis / Q000188:drug therapy* / Q000473:pathology
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept